News|Articles|August 13, 2025
Decentralized Trials: The Value of Direct-to-Patient & Pharmacy-Led Solutions
Author(s)Catalent
Key Takeaways
Discover how pharmacy-led models in direct-to-patient clinical supply are pivotal in modernizing clinical trials, offering scalable, patient-centric solutions that align with regulatory guidance and industry trends. Strategic collaboration with pharmacy providers is the key to unlocking the full potential and benefits of decentralized clinical trials (DCTs).
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
3
FDA Deploys Agentic AI Capabilities for Agency Staff
4
PharmTech Weekly News Roundup – Week of December 1, 2025
5
